Pregnancy Loss and Cardiovascular Diseases in Women: Recent Findings and Potential Mechanisms Mette Marie Babiel Schmidt PetersenTanja Schlaikjær HartwigHenriette Svarre Nielsen Women and Ischemic Heart Disease (J.M. Peña and F. Lin, Section Editors) 16 November 2022 Pages: 889 - 899
Social Media and Cardiovascular Health: Implications for Women Rachel E. GoodmanMorgan LambergSherry-Ann Brown Women and Ischemic Heart Disease (J.M. Peña and F. Lin, Section Editors) 28 November 2022 Pages: 901 - 913
CETP Inhibitors: Should We Continue to Pursue This Pathway? Stephen J. NichollsAdam J. Nelson Nonstatin Drugs (L. Tokgozoglu and A.L. Catapano, Section Editors) 21 November 2022 Pages: 915 - 923
Transitioning to GLP-1 RAs and SGLT2 Inhibitors as the First Choice for Managing Cardiometabolic Risk in Type 2 Diabetes Kunal K. JhaRishav AdhikariMichael J. Blaha Evidence-Based Medicine, Clinical Trials and Their Interpretations (K. Nasir, Section Editor) 24 November 2022 Pages: 925 - 937
A Contemporary Review of Epidemiology, Risk Factors, Etiology, and Outcomes of Premature Stroke Thomas B. H. PotterJonika TannousFarhaan S. Vahidy Evidence-Based Medicine, Clinical Trials and Their Interpretations (K. Nasir, Section Editor) Open access 14 November 2022 Pages: 939 - 948
Evolution of Coronary Calcium Screening for Assessment of Atherosclerotic Cardiovascular Disease Risk and Role in Preventive Cardiology Nathan D. Wong Evidence-Based Medicine, Clinical Trials and Their Interpretations (K. Nasir, Section Editor) Open access 14 November 2022 Pages: 949 - 957
ANGPTL3 as a Drug Target in Hyperlipidemia and Atherosclerosis Farzahna MohamedBrett S. MansfieldFrederick J. Raal Genetics and Genomics (R.A. Hegele, Section Editor) 11 November 2022 Pages: 959 - 967
The Dynamic Interplay of Healthy Lifestyle Behaviors for Cardiovascular Health Penny M. Kris-EthertonPhilip A. SappOlivia Lawler Nutrition (K. Petersen, Section Editor) Open access 24 November 2022 Pages: 969 - 980
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 European Society of Cardiology Congress Melody HermelMegan PelterSalim S. Virani Reviews and Scientific Meetings and New Research Implications (S. Virani, Section Editor) 08 November 2022 Pages: 981 - 993
PCSK9 Inhibition and Risk of Diabetes: Should We Worry? Stefano CarugoCesare R. SirtoriMassimiliano Ruscica Cardiometabolic Disease and Treatment (R. Santos, Section Editor) Open access 16 November 2022 Pages: 995 - 1004